Physiological studies of transgenic mice overexpressing growth hormone (GH) secretagogue receptor 1A in GH-releasing hormone neurons. 2004

Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
Division of Molecular Neuroendocrinology, National Institute for Medical Research, London, United Kingdom.

The type 1A GH secretagogue (GHS) receptor (GHSR) has been proposed to mediate the effects of ghrelin on GH release, food intake, and body composition. We have overexpressed GHSR in GH-producing GC cells and GHRH neurons in an attempt to enhance signaling via this pathway selectively, in the GH axis. Constitutive overexpression of human GHSR in rat GC cell lines resulted in increased basal phosphoinositol turnover and rendered them responsive to GHS ligands. We then generated transgenic mice overexpressing human GHSR in GHRH neurons using a 38-kb rat GHRH cosmid promoter. GHRH-GHSR transgenic mice showed increased hypothalamic GHRH expression, pituitary GH contents, and postweaning growth rates. Body weights of the transgenic mice became similar in adulthood, whereas adipose mass was reduced, particularly so in female GHRH-GHSR mice. Organ and muscle weights of transgenic mice were increased despite chronic exposure to a high fat diet. These results suggest that constitutive overexpression of GHSR in GHRH neurons up-regulates basal activity in the GHRH-GH axis. However, GHRH-GHSR mice showed no evidence of increased sensitivity to acute or chronic treatment with exogenous GHS ligands. Food intake and adipose tissue responses to chronic high fat feeding and treatment with GHS ligands were unaffected, as were locomotor and anxiety behaviors, although GHRH-GHSR mice remained significantly leaner than wild-type littermates. Thus, constitutive overexpression of GHSR can up-regulate basal signaling activity in the GHRH/GH axis and reduce adiposity without affecting other GHSR-mediated signals.

UI MeSH Term Description Entries
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell

Related Publications

Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
July 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
November 1999, The Journal of endocrinology,
Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
January 2003, Experimental diabesity research,
Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
February 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
February 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
September 2004, Nihon rinsho. Japanese journal of clinical medicine,
Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
November 2000, Journal of medicinal chemistry,
Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
August 1996, The EMBO journal,
Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
August 2006, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi,
Sabrina Lall, and Nina Balthasar, and Danielle Carmignac, and Charamboulos Magoulas, and Abdul Sesay, and Pamela Houston, and Kathleen Mathers, and Iain Robinson
March 2000, The American journal of pathology,
Copied contents to your clipboard!